Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 7Neoplasm Metastasis 4Recurrence 3Non Small Cell Lung Cancer Metastatic 3Neuroblastoma 3Neoplasms 3Meningeal Carcinomatosis 2Brain Neoplasms 2Advanced Non-Small Cell Lung Cancer 2Thrombocytosis 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Non-Small Cell Lung Cancer ALK-positive 1Non Small Cell Lung Cancer ALK Positive or ROS1 Positive 1Neurofibromatosis 1 1Neoadjuvant Non-Small Cell Lung Cancer 1NSCLC 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lung Diseases 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Psychiatric Rehabilitation 6Surveys and Questionnaires 5Counseling 4Therapeutics 3Radiotherapy 3Sildenafil Citrate 2High-Intensity Focused Ultrasound Ablation 2Exercise 2trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alectinib 1Vitamin E 1Vitamin D 1Uterine Myomectomy 1Testosterone Propionate 1Testosterone 1Tadalafil 1Surgical Procedures, Operative 1Sexual Health 1Sex Education 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sexual Dysfunction, Physiological × lorlatinib × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡